24.74
-0.80 (-3.13%)
| Penutupan Terdahulu | 25.54 |
| Buka | 27.20 |
| Jumlah Dagangan | 11,878,649 |
| Purata Dagangan (3B) | 17,581,885 |
| Modal Pasaran | 5,632,024,064 |
| Harga / Pendapatan (P/E TTM) | 46.68 |
| Harga / Pendapatan (P/E Ke hadapan) | 44.84 |
| Harga / Jualan (P/S) | 3.11 |
| Harga / Buku (P/B) | 10.61 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 23 Feb 2026 |
| Margin Keuntungan | 9.21% |
| Margin Operasi (TTM) | 10.12% |
| EPS Cair (TTM) | 0.680 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 110.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 344.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.54% |
| Nisbah Semasa (MRQ) | 1.59 |
| Aliran Tunai Operasi (OCF TTM) | 334.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 213.45 M |
| Pulangan Atas Aset (ROA TTM) | 10.76% |
| Pulangan Atas Ekuiti (ROE TTM) | 36.79% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Hims & Hers Health, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -0.13 |
|
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 11.13% |
| % Dimiliki oleh Institusi | 82.47% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Farallon Capital Management Llc | 30 Sep 2025 | 10,746,852 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 60.00 (BTIG, 142.52%) | Beli |
| Median | 48.00 (94.02%) | |
| Rendah | 33.00 (Evercore ISI Group, 33.39%) | Pegang |
| Purata | 47.00 (89.98%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 32.87 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 02 Feb 2026 | 60.00 (142.52%) | Beli | 26.44 |
| Evercore ISI Group | 12 Jan 2026 | 33.00 (33.39%) | Pegang | 32.34 |
| Barclays | 09 Dec 2025 | 48.00 (94.02%) | Beli | 39.82 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |